The FDA has approved a generic daily injectable, the liraglutide injection, for patients aged 10 years and up who have Type 2 diabetes. This injectable, sold under the name Victoza, which is currently in short supply, offers a more affordable solution for those requiring GLP-1 medications. However, patients with particular medical conditions are advised against using the medicine.
Cyber incident disrupts services at Marks & Spencer – Digital Watch Observatory
A cyber incident has disrupted services at Marks & Spencer, affecting operations significantly. The Digital Watch Observatory reported that the breach led to service interruptions,
